Adherence in adults with type 1 diabetes mellitus correlates with treatment satisfaction but not with adverse events

Patient Preference and Adherence

Volumn 7, Issue , 2013, Pages 867-876

  Hendrychova, Tereza ^a   Vytrisalova, Magda ^a   Smahelova, Alena ^b   Vlcek, Jiri ^a   Kubena, Ales Antonin ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Diabetes treatment satisfaction questionnaire; Self care inventory revised; Self monitoring; Treatment adherence

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN DERIVATIVE;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; CZECH REPUBLIC; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INJECTION SITE REACTION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PATIENT SATISFACTION; SELF CARE; SELF MONITORING; SMOKING HABIT; TREATMENT OUTCOME;

EID: 84884149152     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S47750     Document Type: Article

References (39)

1. American Diabetes Association. Standards of medical care in diabetes 2011. Diabetes Care. 2011;34 Suppl 1:S11-S61.
2. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia. 2002;45(7): 937-948.
3. Toljamo M, Hentinen M. Adherence to self-care and glycaemic control among people with insulin-dependent diabetes mellitus. J Adv Nurs. 2001;34(6):780-786.
4. Sabate E, editor. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
5. Larsen J, Stovring H, Kragstrup J, Hansen DG. Can differences in medical drug compliance between European countries be explained by social factors: analyses based on data from the European Social Survey, round 2. BMC Public Health. 2009;9:145.
6. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.
7. Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62(1): 76-87.
8. Hughes DA, Bagust A, Haycox A, Walley T. The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ. 2001;10(7):601-615.
9. Boudes P. Drug compliance in therapeutic trials: a review. Control Clin Trials. 1998;19(3):257-268.
10. Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74-109.
11. Barbosa CD, Balp MM, Kulich K, Germain N, Rofail D. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 2012;6:39-48.
12. Hood KK, Peterson CM, Rohan JM, Drotar D. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics. 2009;124(6):e1171-e1179.
13. Naar-King S, Idalski A, Ellis D, et al. Gender differences in adherence and metabolic control in urban youth with poorly controlled type 1 diabetes: the mediating role of mental health symptoms. J Pediatr Psychol. 2006;31(8):793-802.
14. Kyngas H, Rissanen M. Support as a crucial predictor of good compliance of adolescents with a chronic disease. J Clin Nurs. 2001;10(6): 767-774.
15. Kyngäs HA. Predictors of good adherence of adolescents with diabetes (insulin-dependent diabetes mellitus). Chronic Illn. 2007;3(1): 20-28.
16. Johnson SB. Methodological issues in diabetes research. Measuring adherence. Diabetes Care. 1992;15(11):1658-1667.
17. Ruggiero L, Glasgow RE, Dryfoos JM, et al. Diabetes self-management: Self-reported recommendations and patterns in a large population. Diabetes Care. 1997;20(4):568-576.
18. Guo J, Whittemore R, He GP. The relationship between diabetes self-management and metabolic control in youth with type 1 diabetes: an integrative review. J Adv Nurs. 2011;67(11):2294-2310.
19. La Greca A. The Self Care Inventory-Revised. Miami: University of Miami, Department of Psychology; 2005. Available from: http://www.psy.miami.edu/faculty/alagreca/SCI-R.pdf. Accessed May 21, 2012.
20. Bradley C. Diabetes treatment satisfaction questionnaire. In: Bradley C, editors. Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Harwood Academic Publisher: Chur; 1994:111-132.
21. Weinger K, Butler HA, Welch GW, La Greca AM. Measuring diabetes self-care: a psychometric analysis of the Self-Care Inventory-Revised with adults. Diabetes Care. 2005;28(6):1346-1352.
22. La Greca A. Manual for the Self Care Inventory. Miami; University of Miami, Department of Psychology; 2004. Available from: http://www.psy.miami.edu/faculty/alagreca/SCI_manual_2004.pdf. Accessed May 21, 2012.
23. Bradley C. DTSQs and DTSQc User Guidelines. London: Royal Holloway University of London, Health Psychology Research; 2010. Available from: http://www.healthpsychologyresearch.com/Admin/uploaded/Guidelines/dtsqs&cuserguidelines_rev.17.3.10.pdf. Accessed May 21, 2012.
24. Cohen J. A power primer. Psychol Bull. 1992;112(1):155-159.
25. Broadbent E, Donkin L, Stroh JC. Illness and treatment perceptions are associated with adherence to medications, diet, and exercise in diabetic patients. Diabetes Care. 2011;34(2):338-340.
26. Hoogma RP, Spijker AJ, van Doorn-Scheele M, et al. Quality of life and metabolic control in patients with diabetes mellitus type 1 treated by continuous subcutaneous insulin infusion or multiple daily insulin injections. Neth J Med. 2004;62(10):383-387.
27. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care. 2002;25(11):2074-2080.
28. Nicolucci A, Maione A, Franciosi M, et al; EQuality1 Study Group Evaluation of QUALITY of Life and Costs in Diabetes Type 1. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med. 2008;25(2):213-220.
29. Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev. 2002; 18 Suppl 3:S64-S69.
30. Goodall TA, Halford WK. Self-management of diabetes mellitus: a critical review. Health Psychol. 1991;10(1):1-8.
31. Dibonaventura M, Gabriel S, Dupclay L, Gupta S, Kim E. A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia. BMC Psychiatry. 2012;12:20.
32. Miyachi Y, Hayashi N, Furukawa F, et al. Acne management in Japan: study of patient adherence. Dermatology (Basel). 2011;223(2): 174-181.
33. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care. 2003;26(4):1079-1087.
34. Retnakaran R, Hochman J, DeVries JH, et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care. 2004;27(11):2590-2596.
35. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ. 2002;324(7339):705.
36. Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med. 2001;161(19):2293-2300.
37. Rabiau MA, Knäuper B, Nguyen TK, Sufrategui M, Polychronakos C. Compensatory beliefs about glucose testing are associated with low adherence to treatment and poor metabolic control in adolescents with type 1 diabetes. Health Educ Res. 2009;24(5):890-896.
38. Nau DP, Aikens JE, Pacholski AM. Effects of gender and depression on oral medication adherence in persons with type 2 diabetes mellitus. Gend Med. 2007;4(3):205-213.
39. Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med. 2005;165(21):2508-2513.